U.S., Jan. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07312799) titled 'Evaluate the Pharmacokinetic Interaction and the Safety of AD-2321 and AD-2322' on Dec. 17, 2025.
Brief Summary: To evaluate the pharmacokinetic interactions of AD-2321, AD-2322 in healthy adult volunteers.
Study Start Date: Jan. 27
Study Type: INTERVENTIONAL
Condition:
Hypertension
Intervention:
DRUG: Treatment A(AD-2321)
AD-2321 Oral Tablet
DRUG: Treatment B(AD-2322)
AD-2322 Oral Tablet
DRUG: Treatment C(AD-2321+AD-2322)
AD-2321 Oral Tablet+AD-2322 Oral Tablet
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Addpharma Inc.
Disclaimer: Curated by HT Syndication....